BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, focusing on diverse patient populations, including individuals with intellectual and developmental disabilities and those in need of rehabilitation support. The company prioritizes personalized, high-quality care, facilitated by a dedicated and skilled workforce that significantly improves patient outcomes and quality of life. With robust investments in innovative technologies and a strong commitment to value-based care, BrightSpring is well-positioned to capitalize on growth opportunities within the dynamic healthcare landscape, highlighting its potential for sustainable, long-term success.
| Revenue (TTM) | $15.25B |
| Gross Profit (TTM) | $1.91B |
| EBITDA | $693.87M |
| Operating Margin | 3.81% |
| Return on Equity | 15.50% |
| Return on Assets | 5.44% |
| Revenue/Share (TTM) | $74.23 |
| Book Value | $10.51 |
| Price-to-Book | 6.02 |
| Price-to-Sales (TTM) | 0.88 |
| EV/Revenue | 0.968 |
| EV/EBITDA | 21.75 |
| Quarterly Earnings Growth (YoY) | 82.00% |
| Quarterly Revenue Growth (YoY) | 26.40% |
| Shares Outstanding | $198.99M |
| Float | $151.28M |
| % Insiders | 3.08% |
| % Institutions | 107.26% |
Volatility is currently expanding
BrightSpring surged 11.3% in a week as strong pharmacy growth, rising profits and higher 2026 guidance fueled gains, but its premium valuation raises concerns.
BrightSpring's specialty pharmacy growth, Provider Services expansion and operational gains fuel optimism, but IRA pressures and integration risks remain.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
BTSG's Q3 2026 earnings surge 80% as strong pharmacy and home health growth fuel a revenue beat, margin expansion and higher full-year guidance.
BrightSpring raises 2026 guidance after a Q3 earnings beat, as specialty drug launches and home health gains support its outlook for organic growth in 2027.
BrightSpring Health Services, Inc. (BTSG) Q3 2026 Earnings Call Transcript
BrightSpring Health Services NASDAQ: BTSG reported third-quarter results above its forecast, with revenue rising 26% year over year to $4.2 billion and adjusted EBITDA increasing 42% to $228 million. Adjusted earnings per share were $0.54, up 80% from the prior-year quarter and 20% sequentially, while operating cash flow exceeded $200 million.
The headline numbers for BrightSpring Health Services, Inc. (BTSG) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
BrightSpring Health Services, Inc. (BTSG) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.3 per share a year ago.
LOUISVILLE, Ky., Oct. 30, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home- and community-based health services for complex populations, today announced financial results for the third quarter ended September 30, 2026, and increased full year 2026 Revenue and Adjusted EBITDA1 guidance.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BTSG and any ticker you trade — then tracks every position and per-strategy win rate.
